1. Gabexate for the Prevention of Pancreatic Damage Related to Endoscopic Retrograde Cholangiopancreatography
- Author
-
Cavallini, G, Tittobello, A, Frulloni, L, Masci, E, Mariani, A, Difrancesco, V, Angelini, Gp, Casarini, Mb, Bedogni, G, Conigliaro, R, Bonardi, L, Khajekini, Mta, Cipolletta, L, Bianco, Ma, Costamagna, G, Perri, V, Dobrilla, G, Depretis, G, Familiari, Luigi, Giacobbe, Giuseppa, Fratton, A, Carone, N, Loriga, P, Muscas, A, Mazzeo, F, Gaeta, L, Miglioli, M, Pezzilli, R, Morelli, A, Santucci, L, Naccarato, R, Delfavero, G, Orlandi, F, Macarri, Gp, Russo, A, Virgilio, C, Uomo, G, and Manes, G.
- Subjects
medicine.medical_specialty ,Serine Proteinase Inhibitors ,Pancreatic disease ,Randomization ,Gabexate ,Cholangiopancreatography ,Double-Blind Method, Female, Gabexate, Humans, Lipase, Pancreatitis, Serine Proteinase Inhibitors ,Placebo ,Gastroenterology ,chemistry.chemical_compound ,Double-Blind Method ,Internal medicine ,medicine ,Humans ,Endoscopic retrograde cholangiopancreatography ,medicine.diagnostic_test ,business.industry ,Lipase ,General Medicine ,medicine.disease ,Pancreatitis ,chemistry ,Acute pancreatitis ,Female ,business ,Complication - Abstract
Background Endoscopic retrograde cholangiopancreatography (ERCP) is associated with elevated levels of pancreatic enzymes and pancreatitis. Gabexate, a protease inhibitor, has been used to prevent pancreatic damage related to ERCP. Methods We conducted a multicenter, double-blind comparison of gabexate (1 g given by intravenous infusion starting 30 to 90 minutes before endoscopy and continuing for 12 hours afterward) with placebo (mannitol and sodium chloride, administered in the same fashion). A total of 435 adults scheduled to undergo ERCP and, when indicated, endoscopic sphincterotomy underwent randomization; 17 were excluded from the final analysis for various reasons. The remaining 418 patients (mean age, 60.4 years) — 208 in the gabexate group and 210 in the placebo group — were analyzed. Acute pancreatitis was considered to be present if serum amylase or lipase levels (or both) were five times greater than the upper limits of normal in association with the onset of pancreatic pain. Results After th...
- Published
- 1996